Literature DB >> 6246534

Tumorigenic transformation induced by a specific fragment of DNA from herpes simplex virus type 2.

R J Jariwalla, L Aurelian, P O Ts'o.   

Abstract

Transfection of Syrian hamster embryo cells with limit digests of Bgl II-, Hpa I-, or Bgl II/Hpa I-cleaved DNA from herpes simplex virus type 2 (strain S-1) but not with salmon sperm DNA resulted in the appearance of refractile, morphologically altered cells at a frequency of 10(-5)/0.005 microgram of viral DNA within two to four passages. Transformed lines manifested reduced serum requirement and anchorage-independent growth and were tumorigenic in newborn hamsters. They expressed ICP10, a viral protein immunologically identical to the cervical-tumor-associated AG-4 antigen. Transforming activity was localized in the 16.5 x 10(6)-dalton Bgl II/Hpa I double-digest fragment CDs-1, which exhibited sequence homology to the Bgl II/Hpa I fragment CD of DNA from herpes simplex virus type 2 strain 333, mapping between coordinates 0.43 and 0.58 on the physical map of strain 333 DNA. This fragment, CD333, was also shown to induce neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246534      PMCID: PMC348697          DOI: 10.1073/pnas.77.4.2279

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Anatomy of herpes simplex virus DNA: strain differences and heterogeneity in the locations of restriction endonuclease cleavage sites.

Authors:  G S Hayward; N Frenkel; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

Review 2.  Experimental evidence for the oncogenic potential of herpes simplex virus.

Authors:  F Rapp; C Reed
Journal:  Cancer Res       Date:  1976-02       Impact factor: 12.701

3.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

4.  A new method for the isolation of herpes simplex virus type 2 DNA.

Authors:  J M Walboomers; J T Schegget
Journal:  Virology       Date:  1976-10-01       Impact factor: 3.616

5.  Proteins of herpesvirus type 2. II. Studies demonstrating a correlation between a tumor-associated antigen (AG-4) and a virion protein.

Authors:  B C Strnad; L Aurelian
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

6.  Biologic and immunologic comparison of two HSV-2 variants: one an isolate from cervical tumor cells.

Authors:  L Aurelian; J D Strandberg
Journal:  Arch Gesamte Virusforsch       Date:  1974

7.  Herpes simplex virus DNA in transformed cells: sequence complexity in five hamster cell lines and one derived hamster tumor.

Authors:  N Frenkel; H Locker; B Cox; B Roizman; F Rapp
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

8.  Antibody to HSV-2 induced tumor specific antigens in serums from patients with cervical carcinoma.

Authors:  L Aurelian; B Schumann; R L Marcus; H J Davis
Journal:  Science       Date:  1973-07-13       Impact factor: 47.728

Review 9.  Immunodiagnostic potential of a virus-coded, tumor-associated antigen (AG-4) in cervical cancer.

Authors:  L Aurelian; B C Strnad; M F Smith
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

10.  Nucleotide sequence of the rightward operator of phage lambda.

Authors:  T Maniatis; A Jeffrey; D G Kleid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

View more
  31 in total

1.  Herpes simplex virus specifies two subunits of ribonucleotide reductase encoded by 3'-coterminal transcripts.

Authors:  M A Swain; D A Galloway
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

2.  Identification of immediate-early-type cis-response elements in the promoter for the ribonucleotide reductase large subunit from herpes simplex virus type 2.

Authors:  J P Wymer; T D Chung; Y N Chang; G S Hayward; L Aurelian
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

3.  Protein kinase activity associated with the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).

Authors:  T D Chung; J P Wymer; C C Smith; M Kulka; L Aurelian
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

4.  Multistep transformation by defined fragments of herpes simplex virus type 2 DNA: oncogenic region and its gene product.

Authors:  Y Hayashi; T Iwasaka; C C Smith; L Aurelian; G K Lewis; P O Ts'o
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

5.  Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene.

Authors:  S Muralidhar; A M Pumfery; M Hassani; M R Sadaie; M Kishishita; J N Brady; J Doniger; P Medveczky; L J Rosenthal
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  Small fragments of herpesvirus DNA with transforming activity contain insertion sequence-like structures.

Authors:  D A Galloway; J A Nelson; J K McDougall
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

Review 7.  Does neoplasia in-situ develop due to the interaction of Epstein-Barr virus or herpes simplex virus-2 with Langerhans cells in the epithelium?

Authors:  Y Becker
Journal:  Virus Genes       Date:  1988-07       Impact factor: 2.332

8.  Characterization of mRNAs that map in the BglII N fragment of the herpes simplex virus type 2 genome.

Authors:  F J Jenkins; M K Howett
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

9.  Herpesvirus-specific RNA and protein in carcinoma of the uterine cervix.

Authors:  J K McDougall; C P Crum; C M Fenoglio; L C Goldstein; D A Galloway
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

10.  Detection of herpes simplex virus type 2 glycoproteins expressed in virus-transformed rat cells.

Authors:  J G Lewis; L S Kucera; R Eberle; R J Courtney
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.